

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.10274090 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.10274090 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.37243859 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.60438211 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23942037 |
| 6 | response to peptidoglycan (GO:0032494) | 4.53183495 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.48602566 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42868551 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.39909222 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10896136 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.02961137 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 3.97236568 |
| 13 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.95237782 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84938729 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84938729 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.84938729 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84938729 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.84938729 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84938729 |
| 20 | protein localization to endosome (GO:0036010) | 3.84275590 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.81666443 |
| 22 | negative regulation of phagocytosis (GO:0050765) | 3.73780021 |
| 23 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.67556861 |
| 24 | leukocyte aggregation (GO:0070486) | 3.65530814 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.65075893 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.62556319 |
| 27 | regulation of B cell differentiation (GO:0045577) | 3.53446536 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45656326 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.43469182 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.40806687 |
| 31 | barbed-end actin filament capping (GO:0051016) | 3.40380370 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34151312 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.29739417 |
| 34 | activation of Rac GTPase activity (GO:0032863) | 3.29217300 |
| 35 | negative T cell selection (GO:0043383) | 3.26956633 |
| 36 | response to interleukin-15 (GO:0070672) | 3.24910729 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24692506 |
| 38 | ribosomal small subunit assembly (GO:0000028) | 3.17975211 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.13220826 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13220826 |
| 41 | stress fiber assembly (GO:0043149) | 3.08835327 |
| 42 | response to type I interferon (GO:0034340) | 3.08497673 |
| 43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.07654703 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.03542591 |
| 45 | T cell migration (GO:0072678) | 3.03519107 |
| 46 | cellular extravasation (GO:0045123) | 3.02144442 |
| 47 | regulation of early endosome to late endosome transport (GO:2000641) | 3.02133239 |
| 48 | hepatocyte apoptotic process (GO:0097284) | 3.01455138 |
| 49 | hemidesmosome assembly (GO:0031581) | 3.00862859 |
| 50 | cellular response to type I interferon (GO:0071357) | 2.99683677 |
| 51 | type I interferon signaling pathway (GO:0060337) | 2.99683677 |
| 52 | definitive hemopoiesis (GO:0060216) | 2.99358264 |
| 53 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95346500 |
| 54 | thymic T cell selection (GO:0045061) | 2.94624266 |
| 55 | pinocytosis (GO:0006907) | 2.94181376 |
| 56 | megakaryocyte development (GO:0035855) | 2.91882510 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 2.90761743 |
| 58 | actin nucleation (GO:0045010) | 2.89771862 |
| 59 | response to muramyl dipeptide (GO:0032495) | 2.89199887 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 2.87486064 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87229526 |
| 62 | response to interferon-beta (GO:0035456) | 2.87145649 |
| 63 | T cell homeostasis (GO:0043029) | 2.86946636 |
| 64 | respiratory burst (GO:0045730) | 2.86645686 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86619213 |
| 66 | leukocyte cell-cell adhesion (GO:0007159) | 2.86577764 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 2.86085576 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85804691 |
| 69 | regulation of integrin activation (GO:0033623) | 2.85573661 |
| 70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85513464 |
| 71 | interferon-gamma production (GO:0032609) | 2.81996327 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.81724395 |
| 73 | detection of other organism (GO:0098543) | 2.79615630 |
| 74 | mast cell activation (GO:0045576) | 2.79378929 |
| 75 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78464762 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.78048211 |
| 77 | positive regulation of macrophage differentiation (GO:0045651) | 2.77851030 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77693514 |
| 79 | mannose metabolic process (GO:0006013) | 2.77540352 |
| 80 | response to laminar fluid shear stress (GO:0034616) | 2.76417336 |
| 81 | B cell mediated immunity (GO:0019724) | 2.76331171 |
| 82 | response to protozoan (GO:0001562) | 2.75767641 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 2.75163810 |
| 84 | positive regulation of receptor recycling (GO:0001921) | 2.74275225 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 2.74018916 |
| 86 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73667206 |
| 87 | skin morphogenesis (GO:0043589) | 2.72483287 |
| 88 | apoptotic process involved in morphogenesis (GO:0060561) | 2.72450596 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70691537 |
| 90 | mesodermal cell differentiation (GO:0048333) | 2.70663586 |
| 91 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70421291 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.69729450 |
| 93 | detection of bacterium (GO:0016045) | 2.68156894 |
| 94 | tolerance induction (GO:0002507) | 2.67759794 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67212675 |
| 96 | regulation of response to interferon-gamma (GO:0060330) | 2.66015967 |
| 97 | hypotonic response (GO:0006971) | 2.64158447 |
| 98 | germinal center formation (GO:0002467) | 2.63893623 |
| 99 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.63014947 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 2.62639579 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 2.62639579 |
| 102 | cellular response to interleukin-15 (GO:0071350) | 2.62261449 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.62034956 |
| 104 | T cell selection (GO:0045058) | 2.61896919 |
| 105 | positive T cell selection (GO:0043368) | 2.61752264 |
| 106 | response to interferon-alpha (GO:0035455) | 2.61297437 |
| 107 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60902915 |
| 108 | glycosphingolipid catabolic process (GO:0046479) | 2.60141413 |
| 109 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58864019 |
| 110 | hyaluronan catabolic process (GO:0030214) | 2.57899488 |
| 111 | regulation of necroptotic process (GO:0060544) | 2.57860096 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57379380 |
| 113 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.56856540 |
| 114 | cell-substrate junction assembly (GO:0007044) | 2.56765856 |
| 115 | defense response to protozoan (GO:0042832) | 2.56308417 |
| 116 | lymphocyte homeostasis (GO:0002260) | 2.55981465 |
| 117 | angiogenesis involved in wound healing (GO:0060055) | 2.55266463 |
| 118 | positive regulation of lamellipodium assembly (GO:0010592) | 2.55110398 |
| 119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55017522 |
| 120 | response to host immune response (GO:0052572) | 2.55017522 |
| 121 | epithelial cell-cell adhesion (GO:0090136) | 2.54857617 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52736908 |
| 123 | viral transcription (GO:0019083) | 2.52418487 |
| 124 | negative regulation of viral release from host cell (GO:1902187) | 2.52041934 |
| 125 | T cell costimulation (GO:0031295) | 2.50244847 |
| 126 | response to progesterone (GO:0032570) | 2.50109168 |
| 127 | regulation of antigen processing and presentation (GO:0002577) | 2.50069494 |
| 128 | response to host (GO:0075136) | 2.49319303 |
| 129 | response to host defenses (GO:0052200) | 2.49319303 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49319303 |
| 131 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49039404 |
| 132 | negative regulation of granulocyte differentiation (GO:0030853) | 2.48450155 |
| 133 | lymphocyte costimulation (GO:0031294) | 2.48374452 |
| 134 | pentose-phosphate shunt (GO:0006098) | 2.48105893 |
| 135 | positive regulation of tolerance induction (GO:0002645) | 2.47422982 |
| 136 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46401424 |
| 137 | detection of external biotic stimulus (GO:0098581) | 2.46182452 |
| 138 | modulation by symbiont of host cellular process (GO:0044068) | 2.45853511 |
| 139 | regulation of superoxide anion generation (GO:0032928) | 2.45177659 |
| 140 | positive regulation of histone deacetylation (GO:0031065) | 2.45130997 |
| 141 | myeloid dendritic cell differentiation (GO:0043011) | 2.44683206 |
| 142 | apoptotic cell clearance (GO:0043277) | 2.43978974 |
| 143 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43514493 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.43407210 |
| 145 | virion attachment to host cell (GO:0019062) | 2.43407210 |
| 146 | detection of molecule of bacterial origin (GO:0032490) | 2.43316866 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.43028848 |
| 148 | glucose catabolic process (GO:0006007) | 2.39385055 |
| 149 | T-helper 1 type immune response (GO:0042088) | 2.37380327 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.35115121 |
| 151 | peptide catabolic process (GO:0043171) | 2.34437094 |
| 152 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.34412432 |
| 153 | glucose 6-phosphate metabolic process (GO:0051156) | 2.32452678 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.32298985 |
| 155 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.32278241 |
| 156 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32200199 |
| 157 | regulation of podosome assembly (GO:0071801) | 2.31251122 |
| 158 | basement membrane organization (GO:0071711) | 2.30164227 |
| 159 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.30102702 |
| 160 | glycolipid catabolic process (GO:0019377) | 2.30041713 |
| 161 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27891568 |
| 162 | regulation of viral release from host cell (GO:1902186) | 2.27773442 |
| 163 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.27139859 |
| 164 | positive regulation of extracellular matrix organization (GO:1903055) | 2.26903416 |
| 165 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24478823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25298270 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.38833740 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32842345 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.31109543 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.25610666 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23901768 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13694102 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05442090 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.90103121 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75051392 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69846330 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69333151 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68419073 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65201531 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57699985 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46191845 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46114809 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43975187 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41618581 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40955497 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40610430 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.31613690 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.30302780 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.27756643 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23957027 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21149064 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20608960 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12789006 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10733512 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07351538 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05505146 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04637943 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03538950 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 2.01779968 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00983283 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00244733 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00135167 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99017701 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98305542 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96695457 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90334848 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85821427 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84141951 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79021746 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76888959 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75586998 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68797923 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65867172 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62499125 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61691052 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57202565 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55772951 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54066918 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53994710 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49101746 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46938030 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46815127 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.46262237 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45196403 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45034419 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44163510 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44058906 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43638122 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43448740 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.37560799 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36012038 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35303073 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35216679 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35081977 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33717962 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32961567 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.29278637 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29030124 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28932357 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28253838 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27312830 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25706221 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24974625 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24071910 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22684494 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22569631 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21511054 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21151678 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18922733 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17960026 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17005442 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16759296 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16300574 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15896955 |
| 90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15498963 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15256084 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15242556 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14953276 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.14849746 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14050502 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13973788 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13864104 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13257318 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13242384 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13140024 |
| 101 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12806512 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12274087 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11649907 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09702991 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07940710 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07802157 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06776309 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06548951 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06055453 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06055453 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05371535 |
| 112 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03362846 |
| 113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03149779 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02998173 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02793848 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01828372 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00585500 |
| 118 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00089127 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99401978 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98506944 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97929371 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96708197 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96649477 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96503156 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95821414 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92115926 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92107935 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89718927 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89393271 |
| 130 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88891855 |
| 131 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.88080827 |
| 132 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87878841 |
| 133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86017548 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84634825 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84404013 |
| 136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83699041 |
| 137 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.83253470 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82132422 |
| 139 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80222808 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80088989 |
| 141 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79754603 |
| 142 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79288415 |
| 143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76379897 |
| 144 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76255225 |
| 145 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.74612343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.52220174 |
| 2 | MP0000685_abnormal_immune_system | 2.97826794 |
| 3 | MP0005671_abnormal_response_to | 2.81190654 |
| 4 | MP0003436_decreased_susceptibility_to | 2.79638659 |
| 5 | MP0001800_abnormal_humoral_immune | 2.62677762 |
| 6 | MP0005451_abnormal_body_composition | 2.57765331 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.56296747 |
| 8 | MP0005387_immune_system_phenotype | 2.51174334 |
| 9 | MP0001790_abnormal_immune_system | 2.51174334 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.50527163 |
| 11 | MP0009785_altered_susceptibility_to | 2.50454830 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.44790807 |
| 13 | MP0003303_peritoneal_inflammation | 2.44339168 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.42366019 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.40057959 |
| 16 | MP0005025_abnormal_response_to | 2.39943898 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.32520773 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.30168586 |
| 19 | MP0001819_abnormal_immune_cell | 2.30154121 |
| 20 | MP0002419_abnormal_innate_immunity | 2.27175324 |
| 21 | MP0002723_abnormal_immune_serum | 2.26560600 |
| 22 | MP0003724_increased_susceptibility_to | 2.20295845 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.19300286 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 2.19248782 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.18418301 |
| 26 | MP0002398_abnormal_bone_marrow | 2.15403484 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 2.14805820 |
| 28 | MP0001849_ear_inflammation | 2.01087154 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 2.00047717 |
| 30 | MP0006082_CNS_inflammation | 1.99345491 |
| 31 | MP0000716_abnormal_immune_system | 1.97177171 |
| 32 | MP0001873_stomach_inflammation | 1.95256967 |
| 33 | MP0002405_respiratory_system_inflammati | 1.95235316 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.94792160 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.93097651 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.92700138 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.88791546 |
| 38 | MP0002722_abnormal_immune_system | 1.84714795 |
| 39 | MP0006054_spinal_hemorrhage | 1.83338592 |
| 40 | MP0009278_abnormal_bone_marrow | 1.81491645 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.80612359 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.80612359 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.75943190 |
| 44 | MP0008260_abnormal_autophagy | 1.74786734 |
| 45 | MP0002429_abnormal_blood_cell | 1.72640050 |
| 46 | MP0004947_skin_inflammation | 1.70645424 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.69725591 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.68296556 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.64988203 |
| 50 | MP0000490_abnormal_crypts_of | 1.58967464 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.57627329 |
| 52 | MP0001853_heart_inflammation | 1.56912314 |
| 53 | MP0002006_tumorigenesis | 1.56228775 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.53383051 |
| 55 | MP0003866_abnormal_defecation | 1.53095584 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.50651546 |
| 57 | MP0004272_abnormal_basement_membrane | 1.50537983 |
| 58 | MP0000858_altered_metastatic_potential | 1.44163200 |
| 59 | MP0002933_joint_inflammation | 1.42794816 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.42563010 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.33006234 |
| 62 | MP0008469_abnormal_protein_level | 1.32729672 |
| 63 | MP0009840_abnormal_foam_cell | 1.31648534 |
| 64 | MP0005164_abnormal_response_to | 1.26400828 |
| 65 | MP0010307_abnormal_tumor_latency | 1.23515370 |
| 66 | MP0005310_abnormal_salivary_gland | 1.22249177 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.22177206 |
| 68 | MP0003448_altered_tumor_morphology | 1.16691548 |
| 69 | MP0005023_abnormal_wound_healing | 1.15446677 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 1.13625736 |
| 71 | MP0001851_eye_inflammation | 1.12762508 |
| 72 | MP0000343_altered_response_to | 1.12752165 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.12351442 |
| 74 | MP0004510_myositis | 1.10336727 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 1.10205795 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.05609256 |
| 77 | MP0001348_abnormal_lacrimal_gland | 1.05092758 |
| 78 | MP0005360_urolithiasis | 1.04812870 |
| 79 | MP0008004_abnormal_stomach_pH | 1.04006602 |
| 80 | MP0004858_abnormal_nervous_system | 1.02999235 |
| 81 | MP0004883_abnormal_blood_vessel | 0.99398681 |
| 82 | MP0001542_abnormal_bone_strength | 0.98113581 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.97864152 |
| 84 | MP0002060_abnormal_skin_morphology | 0.96446229 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.91048051 |
| 86 | MP0002796_impaired_skin_barrier | 0.90475920 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.90071185 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.89590383 |
| 89 | MP0003075_altered_response_to | 0.89155117 |
| 90 | MP0005165_increased_susceptibility_to | 0.88365699 |
| 91 | MP0005501_abnormal_skin_physiology | 0.87399514 |
| 92 | MP0000604_amyloidosis | 0.86814648 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.85664574 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.84877272 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.83936357 |
| 96 | MP0003828_pulmonary_edema | 0.83811147 |
| 97 | MP0003279_aneurysm | 0.83738300 |
| 98 | MP0002254_reproductive_system_inflammat | 0.82796829 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.82391577 |
| 100 | MP0009764_decreased_sensitivity_to | 0.81633578 |
| 101 | MP0001958_emphysema | 0.81284530 |
| 102 | MP0009763_increased_sensitivity_to | 0.81134787 |
| 103 | MP0001915_intracranial_hemorrhage | 0.78729320 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.78000586 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.77579269 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.76764973 |
| 107 | MP0000249_abnormal_blood_vessel | 0.76442929 |
| 108 | MP0003693_abnormal_embryo_hatching | 0.75443549 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.74176795 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.71584886 |
| 111 | MP0001663_abnormal_digestive_system | 0.71126371 |
| 112 | MP0005390_skeleton_phenotype | 0.70843251 |
| 113 | MP0005166_decreased_susceptibility_to | 0.70180543 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.69739159 |
| 115 | MP0002132_abnormal_respiratory_system | 0.68982500 |
| 116 | MP0001879_abnormal_lymphatic_vessel | 0.68401373 |
| 117 | MP0003795_abnormal_bone_structure | 0.67086776 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.66893885 |
| 119 | MP0000598_abnormal_liver_morphology | 0.66236382 |
| 120 | MP0003091_abnormal_cell_migration | 0.65016022 |
| 121 | MP0000609_abnormal_liver_physiology | 0.64118994 |
| 122 | MP0008007_abnormal_cellular_replicative | 0.64107676 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.58400504 |
| 124 | MP0000313_abnormal_cell_death | 0.57683650 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.57462150 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.56564360 |
| 127 | MP0003045_fibrosis | 0.55895416 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.55713939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.42131884 |
| 2 | Chronic otitis media (HP:0000389) | 4.34790012 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.29739027 |
| 4 | Thrombocytosis (HP:0001894) | 4.17596385 |
| 5 | IgM deficiency (HP:0002850) | 4.09678178 |
| 6 | Myositis (HP:0100614) | 3.81716353 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.78493035 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.75369598 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.65724924 |
| 10 | Abnormality of the nasal mucosa (HP:0000433) | 3.64683165 |
| 11 | Nasal polyposis (HP:0100582) | 3.60223604 |
| 12 | Recurrent viral infections (HP:0004429) | 3.59027143 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.56192099 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.53477327 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.46253273 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.45798367 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.43272676 |
| 18 | Cellulitis (HP:0100658) | 3.34378667 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.27366085 |
| 20 | Petechiae (HP:0000967) | 3.25171509 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.23552880 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20259426 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.16064301 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 3.14788506 |
| 25 | Prolonged bleeding time (HP:0003010) | 3.14101894 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.14084086 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.14023269 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.12081896 |
| 29 | Fragile skin (HP:0001030) | 3.11140249 |
| 30 | Pustule (HP:0200039) | 3.05702500 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.98045693 |
| 32 | Abnormality of T cells (HP:0002843) | 2.94235501 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.93253264 |
| 34 | Hematochezia (HP:0002573) | 2.92538785 |
| 35 | Recurrent skin infections (HP:0001581) | 2.88947188 |
| 36 | Meningitis (HP:0001287) | 2.87475759 |
| 37 | Epistaxis (HP:0000421) | 2.85846945 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84759507 |
| 39 | T lymphocytopenia (HP:0005403) | 2.84477687 |
| 40 | Increased connective tissue (HP:0009025) | 2.77810852 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75357560 |
| 42 | Orchitis (HP:0100796) | 2.72381119 |
| 43 | Colitis (HP:0002583) | 2.71426251 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.71268202 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68915723 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68915723 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.68329663 |
| 48 | Abnormal platelet function (HP:0011869) | 2.67327314 |
| 49 | Impaired platelet aggregation (HP:0003540) | 2.67327314 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.65900500 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.60978199 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.59987392 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.59576971 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59576971 |
| 55 | Lymphopenia (HP:0001888) | 2.58686053 |
| 56 | Arterial thrombosis (HP:0004420) | 2.58230103 |
| 57 | Atrophic scars (HP:0001075) | 2.57188003 |
| 58 | Periodontitis (HP:0000704) | 2.53885203 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49184477 |
| 60 | Vasculitis (HP:0002633) | 2.48757668 |
| 61 | Axonal loss (HP:0003447) | 2.46637743 |
| 62 | Broad face (HP:0000283) | 2.45690781 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45038067 |
| 64 | Obstructive lung disease (HP:0006536) | 2.45038067 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.44681798 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.43978344 |
| 67 | Gingival bleeding (HP:0000225) | 2.43957468 |
| 68 | Chest pain (HP:0100749) | 2.42723808 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.42038389 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.41932987 |
| 71 | Distal upper limb amyotrophy (HP:0007149) | 2.41932987 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38760593 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38760593 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38760593 |
| 75 | Myocardial infarction (HP:0001658) | 2.37638790 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.32639554 |
| 77 | B lymphocytopenia (HP:0010976) | 2.32476401 |
| 78 | Abnormality of B cell number (HP:0010975) | 2.32476401 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.31960840 |
| 80 | Osteomyelitis (HP:0002754) | 2.29230296 |
| 81 | Papilloma (HP:0012740) | 2.27980631 |
| 82 | Verrucae (HP:0200043) | 2.27980631 |
| 83 | Cervical subluxation (HP:0003308) | 2.26991011 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.25519299 |
| 85 | Difficulty climbing stairs (HP:0003551) | 2.25433128 |
| 86 | Fatigue (HP:0012378) | 2.25182061 |
| 87 | Increased IgE level (HP:0003212) | 2.25122885 |
| 88 | Leukocytosis (HP:0001974) | 2.24250587 |
| 89 | Loss of speech (HP:0002371) | 2.20089012 |
| 90 | Bronchitis (HP:0012387) | 2.19774561 |
| 91 | Purpura (HP:0000979) | 2.19639040 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 2.17366393 |
| 93 | Emphysema (HP:0002097) | 2.15311529 |
| 94 | Hyperacusis (HP:0010780) | 2.14914044 |
| 95 | Aneurysm (HP:0002617) | 2.14078951 |
| 96 | Chronic diarrhea (HP:0002028) | 2.13985139 |
| 97 | Thin bony cortex (HP:0002753) | 2.13778612 |
| 98 | IgG deficiency (HP:0004315) | 2.12806055 |
| 99 | Retrobulbar optic neuritis (HP:0100654) | 2.12790646 |
| 100 | Optic neuritis (HP:0100653) | 2.12790646 |
| 101 | Peritonitis (HP:0002586) | 2.11966810 |
| 102 | Aplastic anemia (HP:0001915) | 2.11080728 |
| 103 | Polycythemia (HP:0001901) | 2.10312285 |
| 104 | Granulocytopenia (HP:0001913) | 2.09935803 |
| 105 | Easy fatigability (HP:0003388) | 2.08413985 |
| 106 | Thoracic kyphosis (HP:0002942) | 2.07018520 |
| 107 | Skin ulcer (HP:0200042) | 2.06936322 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 2.06264892 |
| 109 | IgA deficiency (HP:0002720) | 2.05860444 |
| 110 | Increased serum ferritin (HP:0003281) | 2.05758464 |
| 111 | Gingivitis (HP:0000230) | 2.04946211 |
| 112 | Hemoptysis (HP:0002105) | 2.04680931 |
| 113 | Chronic sinusitis (HP:0011109) | 2.04421820 |
| 114 | Increased density of long bones (HP:0006392) | 2.04419479 |
| 115 | Distal lower limb muscle weakness (HP:0009053) | 2.02441775 |
| 116 | Spinal rigidity (HP:0003306) | 2.02219001 |
| 117 | Abnormality of the thoracic spine (HP:0100711) | 2.01761557 |
| 118 | Flat acetabular roof (HP:0003180) | 2.01659909 |
| 119 | Nuclear cataract (HP:0100018) | 2.01542730 |
| 120 | Bone pain (HP:0002653) | 2.01415325 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 2.01063267 |
| 122 | Amaurosis fugax (HP:0100576) | 2.00628774 |
| 123 | Disproportionate tall stature (HP:0001519) | 2.00043840 |
| 124 | Encephalitis (HP:0002383) | 1.97970203 |
| 125 | Amyloidosis (HP:0011034) | 1.97724935 |
| 126 | Eosinophilia (HP:0001880) | 1.97647111 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.96692542 |
| 128 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96424760 |
| 129 | Blue sclerae (HP:0000592) | 1.96285975 |
| 130 | Upper motor neuron abnormality (HP:0002127) | 1.95277623 |
| 131 | Pathologic fracture (HP:0002756) | 1.94977095 |
| 132 | Spondylolisthesis (HP:0003302) | 1.94447753 |
| 133 | Arterial tortuosity (HP:0005116) | 1.92981653 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92711807 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92711807 |
| 136 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92711807 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.92136541 |
| 138 | Hypertensive crisis (HP:0100735) | 1.91931402 |
| 139 | Short nail (HP:0001799) | 1.91720731 |
| 140 | Vascular tortuosity (HP:0004948) | 1.91428020 |
| 141 | Malnutrition (HP:0004395) | 1.90599009 |
| 142 | Lower limb amyotrophy (HP:0007210) | 1.89700976 |
| 143 | Menorrhagia (HP:0000132) | 1.89053551 |
| 144 | Osteolytic defects of the hand bones (HP:0009699) | 1.88928703 |
| 145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87512282 |
| 146 | Hypertriglyceridemia (HP:0002155) | 1.86628590 |
| 147 | Ulnar bowing (HP:0003031) | 1.79710580 |
| 148 | Aortic aneurysm (HP:0004942) | 1.79499889 |
| 149 | Milia (HP:0001056) | 1.75094719 |
| 150 | Wormian bones (HP:0002645) | 1.71629503 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71568276 |
| 152 | Abnormality of oral frenula (HP:0000190) | 1.71035739 |
| 153 | Stridor (HP:0010307) | 1.70504486 |
| 154 | Focal segmental glomerulosclerosis (HP:0000097) | 1.70271875 |
| 155 | Long palpebral fissure (HP:0000637) | 1.66111042 |
| 156 | Joint stiffness (HP:0001387) | 1.65746525 |
| 157 | Ankyloglossia (HP:0010296) | 1.65173459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.41580095 |
| 2 | MST1R | 3.91777995 |
| 3 | EPHA2 | 3.90854831 |
| 4 | ERN1 | 2.96665768 |
| 5 | EEF2K | 2.65302847 |
| 6 | TGFBR2 | 2.47553907 |
| 7 | ZAP70 | 2.45781042 |
| 8 | PRPF4B | 2.38717762 |
| 9 | STK10 | 2.37206827 |
| 10 | JAK3 | 2.33980508 |
| 11 | TYK2 | 2.33940579 |
| 12 | BLK | 2.28080207 |
| 13 | PKN2 | 2.26193568 |
| 14 | KIT | 2.15809910 |
| 15 | MAP2K3 | 2.12451009 |
| 16 | BTK | 2.02702822 |
| 17 | TRIB3 | 1.97954189 |
| 18 | TXK | 1.97464485 |
| 19 | TBK1 | 1.92929985 |
| 20 | LRRK2 | 1.91620734 |
| 21 | TEC | 1.86772812 |
| 22 | KDR | 1.86181626 |
| 23 | LMTK2 | 1.86110039 |
| 24 | MET | 1.75988590 |
| 25 | SMG1 | 1.75729795 |
| 26 | CSF1R | 1.75600818 |
| 27 | ICK | 1.71620602 |
| 28 | IKBKE | 1.67792338 |
| 29 | IRAK4 | 1.66877237 |
| 30 | TAOK3 | 1.63063069 |
| 31 | MAP3K10 | 1.60003549 |
| 32 | FLT3 | 1.59680754 |
| 33 | ITK | 1.55413983 |
| 34 | NME2 | 1.51978279 |
| 35 | GRK6 | 1.49290376 |
| 36 | EPHB2 | 1.47970184 |
| 37 | SYK | 1.42286528 |
| 38 | TGFBR1 | 1.41303462 |
| 39 | JAK1 | 1.39352954 |
| 40 | FES | 1.37044614 |
| 41 | PTK2 | 1.36841691 |
| 42 | PRKD2 | 1.31121170 |
| 43 | RPS6KA4 | 1.29967297 |
| 44 | FGFR4 | 1.28829171 |
| 45 | LCK | 1.26993832 |
| 46 | CSK | 1.25515036 |
| 47 | HCK | 1.25140495 |
| 48 | PDGFRA | 1.24384842 |
| 49 | DDR2 | 1.21183131 |
| 50 | MAP3K14 | 1.20922133 |
| 51 | IRAK2 | 1.20157744 |
| 52 | EPHB1 | 1.18951389 |
| 53 | MST4 | 1.17400214 |
| 54 | BMX | 1.16589200 |
| 55 | PAK4 | 1.14350223 |
| 56 | CDC42BPA | 1.10933942 |
| 57 | RPS6KB2 | 1.09099753 |
| 58 | RIPK1 | 1.08125033 |
| 59 | TTN | 1.07963750 |
| 60 | IKBKB | 1.05668136 |
| 61 | PTK6 | 1.02348712 |
| 62 | IRAK3 | 0.99259525 |
| 63 | MAP3K1 | 0.98326374 |
| 64 | LYN | 0.95339269 |
| 65 | MAP3K3 | 0.92952125 |
| 66 | CLK1 | 0.92515879 |
| 67 | SCYL2 | 0.92417304 |
| 68 | FGR | 0.92039289 |
| 69 | NLK | 0.91050738 |
| 70 | MAPKAPK3 | 0.88629992 |
| 71 | PIM1 | 0.87418804 |
| 72 | TRPM7 | 0.83429349 |
| 73 | PIM2 | 0.81840177 |
| 74 | MATK | 0.81284440 |
| 75 | FGFR3 | 0.80822219 |
| 76 | IRAK1 | 0.79722345 |
| 77 | PDPK1 | 0.76992475 |
| 78 | MAP3K11 | 0.75843421 |
| 79 | MAP3K13 | 0.73100703 |
| 80 | JAK2 | 0.72868294 |
| 81 | NEK2 | 0.72250353 |
| 82 | MOS | 0.70667460 |
| 83 | PASK | 0.69577912 |
| 84 | TESK2 | 0.68330351 |
| 85 | TIE1 | 0.68306677 |
| 86 | MAP3K8 | 0.65581539 |
| 87 | TNK2 | 0.65571125 |
| 88 | GRK7 | 0.64932957 |
| 89 | KSR2 | 0.62630598 |
| 90 | CDK6 | 0.59744633 |
| 91 | RPS6KA2 | 0.59508212 |
| 92 | CHUK | 0.59167998 |
| 93 | NEK9 | 0.58821902 |
| 94 | CDK4 | 0.58574611 |
| 95 | MARK2 | 0.58031772 |
| 96 | CAMKK2 | 0.58028838 |
| 97 | RIPK4 | 0.57537902 |
| 98 | ARAF | 0.56058105 |
| 99 | ABL2 | 0.55536353 |
| 100 | TAOK1 | 0.54385972 |
| 101 | SIK3 | 0.54341304 |
| 102 | BRSK2 | 0.53312726 |
| 103 | MAP3K6 | 0.51098870 |
| 104 | RPS6KA6 | 0.50772662 |
| 105 | STK4 | 0.50753030 |
| 106 | MARK3 | 0.50310848 |
| 107 | PRKG2 | 0.49914409 |
| 108 | PTK2B | 0.47599872 |
| 109 | MAP3K7 | 0.46828782 |
| 110 | SIK1 | 0.45972821 |
| 111 | HIPK2 | 0.45095850 |
| 112 | BRAF | 0.44098419 |
| 113 | MTOR | 0.43375989 |
| 114 | CAMK1D | 0.43288057 |
| 115 | NTRK1 | 0.42407128 |
| 116 | MYLK | 0.40435772 |
| 117 | SIK2 | 0.40096471 |
| 118 | MAPK11 | 0.39964001 |
| 119 | EGFR | 0.39662661 |
| 120 | MAPKAPK2 | 0.39373187 |
| 121 | RPS6KL1 | 0.37109902 |
| 122 | RPS6KC1 | 0.37109902 |
| 123 | PRKCQ | 0.36836576 |
| 124 | PDGFRB | 0.36805941 |
| 125 | ERBB4 | 0.36551019 |
| 126 | CDK12 | 0.35504626 |
| 127 | PRKCH | 0.35213949 |
| 128 | TESK1 | 0.34689583 |
| 129 | STK38 | 0.33932778 |
| 130 | TAOK2 | 0.32321234 |
| 131 | ABL1 | 0.31587780 |
| 132 | MAPK4 | 0.31119869 |
| 133 | PAK1 | 0.30886975 |
| 134 | ILK | 0.30737173 |
| 135 | PIK3CG | 0.30512114 |
| 136 | DYRK1B | 0.29979376 |
| 137 | CDK9 | 0.29033837 |
| 138 | PDK1 | 0.27704154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.12681336 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63431174 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39887707 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36831666 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30056645 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.13181769 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11233421 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08150684 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.07704237 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99606606 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98962466 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90567383 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88811764 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84922300 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.71968731 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 1.68691651 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61794646 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.61700223 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60100552 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59490889 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.58812321 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58099621 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55648608 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51756694 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.49441252 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.49288996 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46386326 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.45660908 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.37200347 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35321173 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34062716 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.32579485 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30901543 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30446712 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.29848397 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28606856 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28491229 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27881930 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.27499404 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.27393127 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.25386820 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24200875 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.21289193 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14622526 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13861030 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10615708 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09337944 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09212875 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08593862 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07448750 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07041549 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06479009 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 1.04989628 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00971235 |
| 55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00223475 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99842254 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.98832947 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98236515 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.97499898 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96674761 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95241885 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94923188 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.90949992 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.89711197 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88892890 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85784208 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.85780086 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85037697 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83423905 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.83077104 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81923831 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80642166 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76212732 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74376314 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74232193 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73911434 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71938008 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71697891 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71186438 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69848666 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67952497 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67947540 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67722184 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67718979 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67401629 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67395674 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64966097 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61279551 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60985674 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60514235 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59989030 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59001159 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58847254 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57628037 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57349162 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57242652 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56610128 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55084266 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53404681 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.52774042 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52640015 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52109553 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.51981725 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.49985732 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.49108536 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48191604 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47148967 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.46996631 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46745442 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45797032 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45598793 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45148541 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44493608 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44245742 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.43956561 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43205344 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42889099 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39500177 |
| 119 | Cell cycle_Homo sapiens_hsa04110 | 0.35689640 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.34416434 |
| 121 | Spliceosome_Homo sapiens_hsa03040 | 0.34184146 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33362173 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33316452 |

